OTC Markets OTCPK - Delayed Quote USD
Transgene SA (TRGNF)
0.7000
0.0000
(0.00%)
At close: June 5 at 8:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
307
307
1,450
3,126
9,993
Operating Expense
28,239.8000
28,239.8000
23,145
32,862
33,739
Operating Income
-27,932.8000
-27,932.8000
-21,695
-29,736
-23,746
Net Non Operating Interest Income Expense
1,687
1,687
7,719
-3,323
3,734
Pretax Income
-33,971
-33,971
-22,328
-32,804
-19,536
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-33,971
-33,971
-22,328
-32,804
-19,536
Diluted NI Available to Com Stockholders
-33,971
-33,971
-22,328
-32,804
-19,536
Basic EPS
-0.29
--
-0.22
-0.33
-0.21
Diluted EPS
-0.29
--
-0.22
-0.33
-0.21
Basic Average Shares
117,141.3790
--
101,490.9090
99,501.9600
91,111.6490
Diluted Average Shares
117,141.3790
--
101,490.9090
99,501.9600
91,111.6490
Total Operating Income as Reported
-35,658
-35,658
-30,047
-29,904
-23,525
Total Expenses
28,239.8000
28,239.8000
23,145
32,862
33,739
Net Income from Continuing & Discontinued Operation
-33,971
-33,971
-22,328
-32,804
-19,536
Normalized Income
-33,971
-33,971
-22,328
-32,798
-19,532
Interest Income
--
--
--
--
4,198
Interest Expense
--
--
168
804
464
Net Interest Income
1,687
1,687
7,719
-3,323
3,734
EBIT
-27,932.8000
-27,932.8000
-21,695
-32,000
-19,072
EBITDA
-26,651.8000
-26,651.8000
-20,123
-30,314
-16,551
Reconciled Depreciation
1,281
1,281
1,572
1,686
2,521
Net Income from Continuing Operation Net Minority Interest
-33,971
-33,971
-22,328
-32,804
-19,536
Total Unusual Items Excluding Goodwill
--
--
-35
-6
-4
Total Unusual Items
--
--
-35
-6
-4
Normalized EBITDA
-26,651.8000
-26,651.8000
-20,123
-30,308
-16,547
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 1/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4DN.F Denali Therapeutics Inc.
12.39
-1.27%
ALINT.PA IntegraGen SA
0.5220
0.00%
ALTHX.PA Theranexus Société Anonyme
0.9400
-3.09%
ARGX.VI argenx SE
512.60
+2.48%
2X1.SG Abivax SA
6.94
+0.43%
PHXM.PA PHAXIAM Therapeutics S.A.
0.2010
+1.52%
ALSEN.PA Sensorion SA
0.4100
+1.23%
OSE.PA OSE Immunotherapeutics SA
5.89
-2.64%
BRNS Barinthus Biotherapeutics plc
0.9950
+0.51%
NANO.PA Nanobiotix S.A.
4.1550
+2.09%